TURANABOLONE
Turanabolone is not a recognized or standard name for any known anabolic steroid. It is possible that there is some confusion with Turanabol or Turinabol, both of which refer to the same well-known anabolic steroid.
Turinabol, also known as Turanabol or 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one, is an anabolic–androgenic steroid (AAS) that was first introduced in 1965 by the East German pharmaceutical company Jenapharm.


TURANABOLONE
Product details
Turanabolone is not a recognized or standard name for any known anabolic steroid. It is possible that there is some confusion with Turanabol or Turinabol, both of which refer to the same well-known anabolic steroid.
Turinabol, also known as Turanabol or 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one, is an anabolic–androgenic steroid (AAS) that was first introduced in 1965 by the East German pharmaceutical company Jenapharm.
Composition:
Turinabol is a derivative of methandienone (also known as Dianabol), modified with a 4-chloro group to reduce its androgenic properties while maintaining strong anabolic effects
Purpose:
- Promote muscle growth and increase strength.
- Enhance red blood cell production, improving oxygen delivery to muscles.
- Accelerate recovery times between workouts.
Indications:
- Athletes and bodybuilders aiming to gain lean muscle mass and improve performance.
Important Considerations:
- Administration: Turinabol is typically administered orally and is known for its milder effects compared to other oral steroids.
- Side Effects: Potential side effects may include hormonal imbalances, liver toxicity, cardiovascular strain, and other adverse effects associated with anabolic steroid use.
- Medical Supervision: It is essential that the use of Turinabol be supervised by a qualified healthcare professional to ensure safety and effectiveness.
For more information about Aquila Pharmaceuticals products, please visit the company’s official website.
AQUILA
There are no question found.
Rating & Review
There are no reviews yet.